Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo
about
MicroRNAs in multiple myeloma and related bone diseaseTG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cellsDevelopment of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivoSynthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stressBlockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myelomaBone marrow microenvironment and the identification of new targets for myeloma therapy.Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.Investigational treatments for multiple myeloma.Emerging drugs in multiple myeloma.Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma.Understanding the molecular biology of myeloma and its therapeutic implications.Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growth.Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.A clinically relevant SCID-hu in vivo model of human multiple myeloma.Mouse models of multiple myeloma: technologic platforms and perspectives.
P2860
Q26770478-12B8DEDA-6659-47DB-AA29-71FBBDD5F769Q34134557-8144A7C4-6280-41D8-9662-901C4C14E6CEQ34634316-D921094A-3156-49EA-B310-7BD77C6BC03CQ35678607-AF2A6CE9-B7BC-4BC9-86A9-C22CF10AF516Q35955745-F15A13A3-A03F-47B1-9347-16713CBBB821Q36110746-57B8192E-8A59-47CF-BD00-8D8AC7787BB2Q36162703-DFF1B9EC-A483-4E32-8226-B12ADAECCEF6Q36367811-B575AB54-26E0-4A89-8D72-9C586DE73B40Q36654336-3EDF849B-0BA9-47CD-9911-0F3981112164Q36758600-BC40F156-851F-4107-8400-D71925C41A92Q38016511-FDCB99C8-158E-4F02-B29C-485027F938DFQ38065305-F76920C8-1142-48CF-8C93-F3098C964275Q38854653-E664FA31-16DE-4DD7-A46E-E0A55F31BD29Q39383614-FF007058-DB88-4A7B-BE62-B8509BF685ACQ40078135-AF147D9D-71CB-4905-91D8-379CEA5CEDD4Q40262487-FB1856CA-2B7C-437A-B754-329E597B8372Q40437300-EC9814F3-9993-4621-852D-2AD8BD6587D7Q55038802-5E7FCEFC-A3AA-4892-8119-C0FC3A7BD097
P2860
Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@ast
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@en
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@nl
type
label
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@ast
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@en
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@nl
prefLabel
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@ast
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@en
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@nl
P2093
P2860
P1433
P1476
Azaspirane (N-N-diethyl-8,8-di ...... ow milieu in vitro and in vivo
@en
P2093
Donald H Picker
Gary S Jacob
Hiroshi Yasui
Kenji Ishitsuka
Makoto Hamasaki
Nikhil C Munshi
Noopur Raje
Norihiko Shiraishi
Paola Neri
Pierfrancesco Tassone
P2860
P304
P356
10.1182/BLOOD-2004-09-3794
P407
P577
2005-06-01T00:00:00Z